[Hong Ju-yeon, Edaily Reporter] South Korea’s pharmaceutical and biotechnology sector advanced broadly on Aug.
17 as stocks related to hair-loss treatments surged following news that the government is reviewing the expansion of National Health Insurance coverage for alopecia treatments.
As the government signaled its intention to frame hair loss as a medical condition requiring treatment rather than a cosmetic issue, JW Shinyak hit the daily upper limit, while Olix and L&C Bio also posted strong gains.
뉴스픽의 주요 문장 추출 기술을 사용하여 “이데일리” 기사 내용을 3줄로 요약한 결과입니다. 일부 누락된 내용이 있어 전반적인 이해를 위해서는 본문 전체 읽기를 권장합니다.